Phase 1/2 Study of the Timing and Efficacy of 3 mg Peg-GCSF in Neo/Adjuvant Dose Dense Breast Cancer Treatment Protocols
oleh: Amol Patel, Abhishek Pathak, Arti Sarin, Divya Shelly, Richa Ranjan, Arashdeep Singh, Tripti Kala, Babitha PV
| Format: | Article |
|---|---|
| Diterbitkan: | Thieme Medical and Scientific Publishers Pvt. Ltd. 2023-07-01 |
Deskripsi
Subjek
3 mg; dose dense protocol; Indian patients; pegylated GCSF; phase 2 study